The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2017

Filed:

Dec. 02, 2014
Applicant:

Sanofi, Paris, FR;

Inventors:

Maria Mendez-Perez, Frankfurt am Main, DE;

Kristin Breitschopf, Frankfurt am Main, DE;

Katrin Lorenz, Frankfurt am Main, DE;

Hartmut Strobel, Frankfurt am Main, DE;

Li-hsing Wang, Frankfurt am Main, DE;

Alexander Schiffer, Frankfurt am Main, DE;

Jochen Goerlitzer, Frankfurt am Main, DE;

Assignee:

SANOFI, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 333/38 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/12 (2006.01); A61K 31/496 (2006.01); C07D 277/56 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 333/48 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 409/12 (2013.01); C07D 277/56 (2013.01); C07D 333/38 (2013.01); C07D 333/48 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention relates to compounds of the formula (I), wherein R1, R2, R3, R4 and X have the meanings indicated in the claims. The compounds of formula I are valuable pharmacologically active compounds. They are highly potent and selective soluble epoxide hydrolase inhibitors and are suitable, for example, for the therapy and prophylaxis of renal failure, diabetic nephropathy, type 2 diabetes mellitus, cardiovascular diseases, inflammatory diseases or could show beneficial effects in pain, dyslipidemia, atherosclerosis wound healing and stroke. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.


Find Patent Forward Citations

Loading…